Glatiramer acetate treatment in PPMS: Why males appear to respond favorably

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations

Medicine, Neurology, Pathology +17

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations

Pharmacy, Neurology, Pharmacotherapy +12

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold et al. · New England Journal of Medicine · 2008 · 2.4K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

Pharmacy, Neurology, Pharmacotherapy +14